Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability
Diabetes · 2023
DOI: 10.2337/db23-0307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Puchong Thirawatananond und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Antigens, Differentiation, T-Lymphocyte, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, The Leona M. and Harry B. Helmsley Charitable Trust, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Costimulation serves as a critical checkpoint for T-cell activation, and several genetic variants affecting costimulatory pathways confer risk for autoimmune diseases. A single nucleotide polymorphism (rs763361) in the CD226 gene encoding a costimulatory receptor increases susceptibility to multiple autoimmune diseases, including type 1 diabetes. We previously found that Cd226 knockout protected NOD mice from disease, but the impact of CD226 on individual immune subsets remained unclear. Our prior reports implicate regulatory T cells (Tregs), as human CD226+ Tregs exhibit reduced suppressive function. Hence, we hypothesized that genomic Cd226 gene deletion would increase Treg stability and that Treg-specific Cd226 deletion would inhibit diabetes in NOD mice. Indeed, crossing NOD.Cd226−/− and a NOD Treg-lineage tracing strain resulted in decreased pancreatic Foxp3-deficient “ex-Tregs.” We generated a novel Treg-conditional knockout (TregΔCd226) strain that displayed decreased insulitis and diabetes incidence. CD226-deficient pancreatic Tregs had increased expression of the coinhibitory counter-receptor T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT). Moreover, NOD splenocytes treated with TIGIT-Fc fusion protein exhibited reduced T-cell proliferation and interferon-γ production following anti-CD3/CD28 stimulation. This study demonstrates that a CD226/TIGIT imbalance contributes to Treg instability in NOD mice and highlights the potential for therapeutic targeting this costimulatory pathway to halt autoimmunity. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL.
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
- Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Gainesville, FL.
ORCID-Profile: Todd M Brusko
Förderung
- NIDDK NIH HHS
- The Leona M. and Harry B. Helmsley Charitable Trust
- National Institute of Diabetes and Digestive and Kidney Diseases
- Diabetes Research Connection
- Juvenile Diabetes Research Foundation United States of America
Zitieren
APA
Thirawatananond, P., Brown, M. E., Sachs, L. K., Arnoletti, J. M., Yeh, W. I., Posgai, A. L., Shapiro, M. R., Chen, Y. G., & Brusko, T. M. (2023). Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability. Diabetes. https://doi.org/10.2337/db23-0307
Vancouver
Thirawatananond P, Brown ME, Sachs LK, Arnoletti JM, Yeh WI, Posgai AL, et al. Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability. Diabetes. 2023. doi:10.2337/db23-0307
BibTeX
@article{Thirawatananond2023,
author = {Thirawatananond, Puchong and Brown, Matthew E and Sachs, Lindsey K and Arnoletti, Juan M and Yeh, Wen-I and Posgai, Amanda L and Shapiro, Melanie R and Chen, Yi-Guang and Brusko, Todd M},
title = {Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db23-0307}
}
EUVIMED